Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

Ruth Ladenstein; Ulrike Pötschger; Dominique Valteau-Couanet; Roberto Luksch; Victoria Castel; Isaac Yaniv; Geneviéve Laureys; Penelope Brock; Jean Michon; Cormac Owens; Toby Trahair; Godfrey Chi Fung Chan; Ellen Ruud; Henrik Schroeder; Maja Beck-Popovic; Günter Schreier; Hans Loibner; Peter F Ambros; Keith Holmes; Maria Rita Castellani; Mark Gaze; Alberto Garaventa; Andrew DJ Pearson; Holger N Lode

doi:10.1016/S1470-2045(18)30578-3

Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

Ruth Ladenstein
, Ulrike Pötschger
, Dominique Valteau-Couanet
, Roberto Luksch
, Victoria Castel
, Isaac Yaniv
, Geneviéve Laureys
, Penelope Brock
, Jean Michon
, Cormac Owens
, Toby Trahair
, Godfrey Chi Fung Chan
, Ellen Ruud
, Henrik Schroeder
, Maja Beck-Popovic
, Günter Schreier
, Hans Loibner
, Peter F Ambros
, Keith Holmes
, Maria Rita Castellani

Mark Gaze, Alberto Garaventa, Andrew DJ Pearson, Holger N Lode

Digital Health Information Systems

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	1617-1629
Seitenumfang	13
Fachzeitschrift	Lancet Oncology
DOIs	https://doi.org/10.1016/S1470-2045(18)30578-3
Publikationsstatus	Veröffentlicht - 2018

Research Field

Exploration of Digital Health

Zugriff auf Dokument

10.1016/S1470-2045(18)30578-3Lizenz: Nicht angegeben

Diese Publikation zitieren

Ladenstein, R., Pötschger, U., Valteau-Couanet, D., Luksch, R., Castel, V., Yaniv, I., Laureys, G., Brock, P., Michon, J., Owens, C., Trahair, T., Chi Fung Chan, G., Ruud, E., Schroeder, H., Beck-Popovic, M., Schreier, G., Loibner, H., Ambros, P. F., Holmes, K., ... Lode, H. N. (2018). Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. Lancet Oncology, 1617-1629. https://doi.org/10.1016/S1470-2045(18)30578-3

@article{48156a4521584fc6bf0e150e3f0b8f4b,

title = "Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial",

author = "Ruth Ladenstein and Ulrike P{\"o}tschger and Dominique Valteau-Couanet and Roberto Luksch and Victoria Castel and Isaac Yaniv and Genevi{\'e}ve Laureys and Penelope Brock and Jean Michon and Cormac Owens and Toby Trahair and \{Chi Fung Chan\}, Godfrey and Ellen Ruud and Henrik Schroeder and Maja Beck-Popovic and G{\"u}nter Schreier and Hans Loibner and Ambros, \{Peter F\} and Keith Holmes and Castellani, \{Maria Rita\} and Mark Gaze and Alberto Garaventa and Pearson, \{Andrew DJ\} and Lode, \{Holger N\}",

year = "2018",

doi = "10.1016/S1470-2045(18)30578-3",

language = "English",

pages = "1617--1629",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

}

Ladenstein, R, Pötschger, U, Valteau-Couanet, D, Luksch, R, Castel, V, Yaniv, I, Laureys, G, Brock, P, Michon, J, Owens, C, Trahair, T, Chi Fung Chan, G, Ruud, E, Schroeder, H, Beck-Popovic, M, Schreier, G, Loibner, H, Ambros, PF, Holmes, K, Castellani, MR, Gaze, M, Garaventa, A, Pearson, ADJ & Lode, HN 2018, 'Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial', Lancet Oncology, S. 1617-1629. https://doi.org/10.1016/S1470-2045(18)30578-3

TY - JOUR

T1 - Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

AU - Ladenstein, Ruth

AU - Pötschger, Ulrike

AU - Valteau-Couanet, Dominique

AU - Luksch, Roberto

AU - Castel, Victoria

AU - Yaniv, Isaac

AU - Laureys, Geneviéve

AU - Brock, Penelope

AU - Michon, Jean

AU - Owens, Cormac

AU - Trahair, Toby

AU - Chi Fung Chan, Godfrey

AU - Ruud, Ellen

AU - Schroeder, Henrik

AU - Beck-Popovic, Maja

AU - Schreier, Günter

AU - Loibner, Hans

AU - Ambros, Peter F

AU - Holmes, Keith

AU - Castellani, Maria Rita

AU - Gaze, Mark

AU - Garaventa, Alberto

AU - Pearson, Andrew DJ

AU - Lode, Holger N

PY - 2018

Y1 - 2018

U2 - 10.1016/S1470-2045(18)30578-3

DO - 10.1016/S1470-2045(18)30578-3

M3 - Article

SN - 1470-2045

SP - 1617

EP - 1629

JO - Lancet Oncology

JF - Lancet Oncology

ER -